Search the Newsreel

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

NeoGenomics, Inc. has appointed Carolyn Starrett to its Board of Directors. Ms. Starrett brings over 25 years of experience in commercial, product, and operations roles at data and technology companies, with significant expertise in AI and data insights in cancer care. Her appointment is …

Kenon Holdings Ltd (KEN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Kenon Holdings Ltd (KEN), focusing on future EPS, revenue, and net profit growth estimates. It includes current stock information such as market cap and P/E ratio, alongside a peer comparison for other electric utility companies. The data …

Noticias de acciones de Bionano Genomics Inc (BNGO)

Cenovus Energy (NYSE:CVE) Raised to "Strong-Buy" at Wall Street Zen

Wall Street Zen has upgraded Cenovus Energy (NYSE:CVE) from a "buy" to a "strong-buy" rating. This upgrade comes as the company reported quarterly earnings in line with estimates and revenue that exceeded analyst expectations by 47.9% year-over-year. Despite the stock opening near its 52-week …

Freenome, Inc. (FRNM) stock price, news, quote and history

This article provides an overview of Freenome, Inc. (FRNM) stock performance, including its current price, news, and historical data. It details the company's stock price movement, key financial metrics like trailing total returns against the S&P 500, and lists relevant market data. The content …

Enovis (ENOV) Stock Eyes Margin Gains as Free Cash Flow Improves

Enovis (ENOV) stock saw a modest 1.1% increase despite reporting significant improvements in its Q2 financials, including a narrowed net loss, improved gross and EBITDA margins, and positive free cash flow of US$31 million. The company's future prospects hinge on translating operational progress into …

If You Invested $100 In Enova International Stock 5 Years Ago, You Would Have This Much Today

Enova International (NYSE: ENVA) has shown significant outperformance over the past five years, achieving an average annual return of 50.82%. An initial investment of $100 in ENVA stock five years ago would now be worth $779.22. This demonstrates the substantial impact of compounded returns …

BioNano Genomics Inc (0A4K) Q1 2026 Earnings Report - Results, Call & Slides

BioNano Genomics Inc. (0A4K) reported its Q1 2026 earnings, beating analyst expectations with an EPS of -$0.76 against a consensus of -$0.88 and revenue of $6.69M, surpassing the expected $6.57M. The company highlighted positive operational developments including record flow cell sales, strong consumables growth, …

10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash

Earnings Preview: RenovoRx to Report Financial Results Post-market on August 12

This article announces that RenovoRx (RNXT) is scheduled to report its financial results after the market closes on August 12, 2026. This preview details the expected date for the release of their earnings report.

XENON PHARMACEUTICALS INC. : WEDBUSH RAISES TARGET PRICE TO $71 FROM $63

Wedbush has increased its target price for Xenon Pharmaceuticals Inc. (XENE.O) shares to $71, up from the previous target of $63. This adjustment suggests an improved outlook from the analyst firm for the pharmaceutical company's stock. The information was released by Reuters on August …

Enovis Corp (ENOV) Stock News Today

Enova International (NYSE: ENVA) grants CEO 7,359 stock options with SARs

Enova International's CEO, Steven E. Cunningham, has been granted 7,359 non-qualified stock options paired with limited stock appreciation rights (SARs) at an exercise price of $257.79 per share. These awards will vest in three equal annual installments starting August 5, 2027, and will expire …

Option grant ties Enova International, Inc. (NYSE: ENVA) payout to control-change offer

Enova International granted Chief Strategy Officer Kirk Chartier a non-qualified stock option with a tandem limited stock appreciation right for 2,095 shares. The options have an exercise price of $257.79 per share and vest in one-third increments annually from August 5, 2027 to August …

Terreno Realty (NYSE: TRNO) plans sale of 8,000 compensation shares

Terreno Realty's affiliate has filed a Form 144 to potentially sell 8,000 shares of its common stock through Wells Fargo Clearing Services, with an indicated aggregate market value of over $542,000. The shares, stemming from compensation awards in 2020 and 2026, are expected to …

Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview

Bionano Genomics, Inc. is projected to report a loss of 68 cents per share, according to this earnings preview. The article, provided by Refinitiv and featured on TradingView News, offers a brief overview of the upcoming financial expectation for BNGO. Readers can access the …

GCM GROSVENOR Q2 2026 Earnings Preview: Recent $GCMG Insider Trading, Hedge Fund Activity, and More

Amphenol Corp (APH) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

RenovoRx Inc (RNXT) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for RenovoRx Inc (RNXT), noting its current earnings forecast score of 8.00 and an average price target of $3.50 based on 4 analysts. It details expected future EPS and revenue figures, and summarizes analyst sentiment as predominantly "Buy".

Enova International (NYSE: ENVA) awards 6,190 stock options to Executive Chairman

Enova International (NYSE: ENVA) has granted its Executive Chairman, David Fisher, 6,190 non-qualified stock options. These options, with an exercise price of $257.79 per share and an expiration date of August 5, 2033, vest in three equal annual installments beginning August 5, 2027, contingent …

Enova International (NYSE: ENVA) awards 1,500 options to CFO Scott

Enova International (NYSE: ENVA) has granted its CFO, Cornelis Scott, 1,500 non-qualified stock options with a limited stock appreciation right. These options have an exercise price of $257.79 per share, expire on August 5, 2033, and vest in three equal increments on August 5, …

Colliers Securities Sticks to Their Buy Rating for Terreno Realty (TRNO)

10x Genomics Q2 Earnings Call Highlights

Key Points Interested in 10x Genomics? Here are five stocks we like better. Atera demand is strong ahead of launch: Booked orders by the end of Q2 exceeded the approximately 40 systems 10x Genomics expects to ship in 2026, with production capacity—not demand—currently limiting …

RenovoRx Inc (RNXT) Stock News Today

Neogenomics stock hits 52-week high at 16.46 USD

NeoGenomics Inc. (NEO) stock has reached a 52-week high of $16.46, driven by strong investor confidence and recent positive financial results. Despite being considered overvalued by InvestingPro analysis, the company's stock has delivered a 170% return over the past year, with analysts predicting profitability …

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics TXG reported a second-quarter 2026 loss of 14 cents per share against earnings of 28 cents in the year-ago quarter, representing a 150% year-over-year decline. Still, the figure beat the Zacks Consensus Estimate of a loss of 23 cents by 38.1%. Revenues …

NeoGenomics (NEO) Is Up 8.4% After Q2 Profit Return And Raised 2026 Outlook – Has The Bull Case Changed?

NeoGenomics (NEO) reported a return to quarterly profitability in Q2 2026 with revenue of US$201.66 million and a net income of US$2.24 million, a significant improvement from a net loss the previous year. Management also narrowed its expected full-year 2026 net loss and slightly …

ServiceNow Inc Stock (NOW) Moved Up by 6.27% on Aug 7: Key Drivers Unveiled

ServiceNow Inc. (NOW) stock surged by 6.27% on August 7, driven by strong quarterly financial results that surpassed expectations, primarily due to the successful monetization of its generative AI capabilities and increased contract values. Wall Street analysts have raised price targets for NOW, citing …

Amphenol approves two-for-one stock split, updates Q3 adjusted EPS and declares Q3 dividend

Amphenol (APH) has announced a two-for-one stock split via a stock dividend, payable on September 2, 2026, with a record date of August 17, 2026. The company also updated its Q3 2026 adjusted diluted EPS guidance to $0.70–$0.71 post-split and declared a Q3 2026 …

Bionano Genomics Inc (BNGO) Stock News Today

This article provides current stock information for Bionano Genomics Inc (BNGO), showing a recent increase of 5.45%. It indicates that more news regarding BNGO's stock, earnings, and analyst ratings will be available soon. The page serves as a hub for financial data and updates …

Enovis Corporation Stock 12‑Month Price Target Cut to $41.25, Implies 37% Upside

The average 12-month price target for Enovis Corporation (ENOV) stock has been lowered from $41.58 to $41.25 by analysts, despite this reduction, the new target still suggests a potential upside of approximately 37% based on the August 5th closing price. The consensus rating for …

Metagenomi Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview

Metagenomi Therapeutics Inc is projected to report a loss of 57 cents per share. This earnings preview from Refinitiv indicates the company's expected financial performance. The full article is available on TradingView, offering unlimited access to news from various sources.

BNGO Q2'26 Earnings: EPS estimate is (0.67) USD

Bionano Genomics, Inc. (BNGO) is scheduled to release its Q2'26 financial results on August 10, after market close. The company is expected to report an estimated revenue of $7.55 million and an estimated earnings per share (EPS) of ($0.67) for the quarter. This article …

Terreno Realty Corporation (NYSE:TRNO) to Issue Dividend Increase - $0.57 Per Share

Terreno Realty Corporation (NYSE:TRNO) announced a quarterly dividend increase to $0.57 per share, payable on October 9th to shareholders of record on September 30th. This represents a 9.6% increase from its previous dividend and an annualized yield of 3.3%. While the current payout ratio …

Cenovus Energy (TSE:CVE) Shares Cross Above 200-Day Moving Average - Time to Sell?

Cenovus Energy (TSE:CVE) shares recently crossed above their 200-day moving average, signaling improved technical momentum. The company reported strong quarterly earnings and increased its dividend, yet insiders have sold a significant number of shares. Analysts maintain a bullish outlook with an average "Buy" rating …

Dimensional Fund Advisors LP Buys 225,588 Shares of NeoGenomics, Inc. $NEO

Dimensional Fund Advisors LP increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 9.2% in the first quarter, purchasing an additional 225,588 shares, bringing its total holdings to 2.67 million shares valued at approximately $19.8 million. This acquisition reflects a broader institutional interest in NeoGenomics, …